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Abstract. Monitoring of hematologic profile in a group of broiler chickens (n = 33) 
was the basis for the evaluation of tolerance and the influence of various doses of 
erythromycin thiocyanate. The investigations required the formation of the 3 homogeneous 
groups (2 experimental and 1 control), each consisting of 11 individuals, 12-19 days of age 
and weighing around 500 g, kept and fed under identical conditions. The individuals from the 
experimental groups were treated for 7 consecutive days with therapeutic (10 
mg/individual/day) and double (20 mg/individual/day) doses of erythromycin. During the 
experiment were performed two sets of hematological investigations (pre-and post-treatment) 
on blood samples collected (on heparin) from the three groups of chickens, consisting in 
determining: the total number of erythrocytes and leukocytes, packed cell volume (PCV) 
hemoglobin concentration (Hb), mean erythrocyte constants, white blood cell counts and 
leucogram. The results were interpreted statistically and compared with reference values. 
Global analysis of the developments registered in the investigated physiological parameters of 
the groups of broiler chickens revealed mean values variations from one group to another, 
falling within physiological limits of the species and category, or with slight deviations from 
some references, respectively the intervals established in the control group. Comparative 
developments of hematological parameters pre-and post-treatment outlined a normal profile 
for the investigated category of broiler chickens, indicating a good tolerance of therapeutic 
and double doses of erythromycin thiocyanate with no negative effects on electrolyte balance 
and erythrocyte homeostasis, erythropoiesis and general erythrocyte functions. An overview 
of the determined leukocyte parameters data, outlined specific aspects of leukocyte 
configuration with a good defensive potential, for the group treated with therapeutic dose and 
also for the one treated with the double dose of erythromycin thiocyanate. Statistical analysis 
of the obtained data showed significant differences (p <0.05) only in case of the control 
group, consisting of a decrease in the percentage of heterophiles from (43.182.71 to 
38.366.50) and an increase in the percentage of lymphocytes (from 37.364.20 to 
42.646.65), due to individual cases of slight heteropenia and/or lymphocytosis. The results 
of the clinical and hematological monitoring of the health status, have led to the identification 
of no potential risks associated with doubling the dose of erythromycin thiocyanate. The 
investigated doses of 10 or 20 mg/individual/day, for a period of 7 consecutive days, lacked 
immediate or delayed adverse reactions respectively signs of immunosuppression. 
 
Keywords: hematology, immunosuppression, adverse reactions, tolerance, drug 
 
 
 278 
INTRODUCTION 
 
The use of hematological investigations in monitoring the health status of birds has 
grown in extent, becoming an indispensable component of the protocols used for testing 
bioequivalence, safety and tolerance of active substances on the target species (Ognean et al, 
2004). Raising poultry in the industrial system, such as broilers, limits the possibility of 
individual administration of medicinal products, the main limiting factor being the increased 
number of birds from these types of facilities (Ognean and Cernea, 2006). 
As an alternative procedure, were developed, for industrial poultry complexes, 
management methods based on administering medicinal products in feed or drinking water, 
with the major disadvantage individual dose uncertainties. 
Erythromycin thiocyanate as active substance is found in the composition of several 
medical products-as a veterinary antibiotic with rapid digestive absorption and main 
elimination in bile and faeces in birds. This antibiotic is fixed in part (84%) to protein and has 
a bioavailability of approximately 35% in birds, achieving peak plasma concentrations of 
0,028 g/ml (at 4 hours for a dose of 10 mg) and has a half-life of 1.5 hours. Erythromycin 
penetrates well into most tissues and fluid compartments, except for cerebrospinal fluid, 
concentrating in the liver, where is excreted through bile in high concentrations up to 50 times 
the level found in plasma (8.9-anhidro erythromycin A 6.9-hemiacetals 3 metabolite) because 
it is inactivated in a small extent by demethylation in the liver (Cristea, 2011). 
Since erythromycin is a broad spectrum antibiotic with curative and preventive use in 
poultry, the purpose of this investigation was to evaluate the influences of various doses of 
orally administered erythromycin thiocyanate on hematological profile of broilers, in view the 
current issue of immunosuppression, tolerance or drug residues (Pop et al., 2002). 
 
MATERIALS AND METHODS 
 
The present research has been integrated into a comprehensive experimental protocol, 
being conducted on a group of broilers (n = 33) coming from an intensive exploitation farm. 
In the experiment were introduced only clinically healthy chickens with hematological and 
clinical parameters within the physiological limits, following an initial evaluation (conducted 
over a period of 7 days pre-treatment). The birds were divided into 2 experimental and 1 
control groups: group I (n = 11), subject to oral therapy with therapeutic dose of erythromycin 
thiocyanate, 10 mg/individual/day for 7 consecutive days, group II (n = 11) subject to oral 
treatment with double dose of erythromycin thiocyanate, 20 mg/individual/day for 7 
consecutive days, group III (n = 11) included untreated controls. The individuals of the 3 
investigated groups were kept in identical feeding and environmental conditions. 
Pre-and post-treatment blood samples were collected on heparin, samples which were 
subject to the following hematological investigations: determination of the total number of 
erythrocytes and leukocytes (hemocytometric method), packed cell volume (microhematocrit 
method), hemoglobin (spectrophotometric method), mean erythrocyte constants and 
leucogram on smears stained panoptically (Dia panoptic method). 
Individual data was statistically analyzed using specialized biostatistics applications 
(Graph Pad Instant V3.0, Microsoft Excel), which allowed calculation of the mean value, 
standard deviation and probability index "p". These parameters were the basis of the final 
statistical analysis of the obtained data. 
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RESULTS AND DISCUSSIONS 
 
During the course of the experiment, clinical and laboratory monitorization of health 
development in the groups of investigated chicken ethics and welfare standards were 
respected, which ensured the relevance of the data and it’s interpretation in the general 
context of medical and veterinary practice. Thus, the overall analysis of the physiological 
parameters evolution in the groups showed mean values oscillations from one group to 
another, falling within physiological limits of the species and category, with few deviations 
from certain sources, or to the ranges established in the control group, kept in identical 
conditions to experimental groups (table 1 and 2). 
Comparative assessments of hematological indices and erythrocyte mean constants in 
the investigated birds, showed characteristic features of normal profile of broilers, indicating a 
good tolerance of therapeutic and double doses of erythromycin thiocyanate and thus the lack 
of obvious side effects on electrolyte balance and erythrocyte homeostasis, erythropoiesis and 
erythrocyte function in general. All this was supported by individual developments, which 
were reflected in the average values, given in table 1. Thus, the mean recorded values of the 
packed cell volume oscillated between a minimum of 37.005.44%, registered post-treatment 
in group II and maximum of 39.68  3.48%, pre-treatment in group I, values considered high 
compared to some reference intervals (22.00 to 35.00%) (Bounous and Stedman, 2000) and 
within physiological intervals by others (24.00 to 43.00%) (Gylstorff, 1983). Hemoglobin 
concentration also showed wide fluctuations, mainly falling within the physiological interval 
of 7-13 g/dL (Bounous and Stedman, 2000), except for the control group, which was below 
the lower limit. Compared to other bibliographic sources (Gylstorff, 1983) the obtained mean 
values were situated below the physiological range (8.90 to 13.50 g/dL), hemoglobin 
concentration also showing a decreasing trend in the experimental and increasing the control 
groups. 
Tab. 1. 
Mean values registered for the main hematological indices in groups of investigated 
chicken 
 
Group/variable 
PCV 
(%) 
Hb 
(g/dL) 
Erythrocytes 
(T/L) 
Mean erythrocyte constants 
MCV 
 (fL) 
MCH  
(pg) 
MCHC 
(g/dL) 
I 
Pre 39.683.48 7.771.03 2.280.19 174.2113.24 34.365.78 19.753.12 
Post 39.234.52 7.471.25 2.340.31 169.2524.04 32.517.34 19.444.43 
II 
Pre 37.913.42 7.271.16 2.310.27 166.4825.95 31.956.98 19.356.98 
Post 37.005.44 7.471.22 2.470.32 152.9332.59 30.706.98 20.684.65 
III 
I 37.005.17 6.881.07 2.680.36 141.1829.49 26.195.66 19.034.12 
F 38.004.86 6.921.03 2.670.40 146.7132.67 26.535.79 18.553.73 
R
1
 22.0-35.0 7.0-13.0 2.50-3.50 90.0-140.0 33.0-47.0 26.0-35.0 
R
2
 24.0-43.0 8.9-13.50 2.20-3.30 120. 0-137.0 - - 
Note: Pre= ante- treatment; Post = post- treatment; I=initial; F=final;  
R
1
 -Bounous DI, Stedman NL: Normal avian hematology (2000); 
R
2 
- Gylstorff I: Handbuch der Geflügelphysiologie (1983). 
 
The total number of erythrocytes presented developments in correlation hemoglobin 
concentration, with mean values of ranging from 2.50 to 3.50 T/L, below the lower limit for 
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experimental groups, the same limits were considered physiologic by Bounous and Stedman 
(2000). However, the decreases observed in this parameter were not considered important; 
because they fell within the physiological range (2.20 to 3.30 T/L) reported by other sources 
(Gylstorff, 1983). 
Oscillations more or less important were present also in the mean erythrocyte 
constants which exceeded the reference values (established by Bounous and Stedman, 2000, 
respectively Gylstorff, 1983) for MCV (90.00 to 140.00 fL) and were situated below the 
lower limit for MCH (33.00 to 47.00 pg) and MCHC (26.00 to 35.00 g/dL). 
The statistical analysis of the values of the hematological parameters registered pre-
and post-treatment were not of significant differences, the value of the probability index "p" 
was greater than 0.05 for each of the determined parameters (table 3). 
An overview of obtained data in the determined leukocyte parameters outlined specific 
aspects with a good defensive potential, both for the group treated with therapeutic and double 
dose of erythromycin thiocyanate. 
The distribution of leukocyte subpopulations proportions also indicated a level high 
tolerance to therapeutic and double doses of erythromycin thiocyanate, and the lack of 
sensitization or adverse effects on leukocyte functions in general and leucopoiesis (table 2, 3). 
 
Tab. 2. 
The mean values of the leucogram in the investigated groups of broilers 
 
Lot/variable 
Leukocytes 
(G/L) 
Leucogram (%) 
heterophile eosinophile basophile lymphocyte monocytes 
I 
Pre 16.693.82 41.006.10 1.360.92 0.821.08 43.187.77 13.643.14 
Post 16.753.40 41.737.00 1.731.35 1.180.98 42.828.10 12.553.27 
II 
Pre 15.162.52 41.558.31 1.911.30 0.820.87 40.648.90 15.093.91 
Post 15.473.02 38.9111.03 1.731.35 0.640.81 43.4511.59 15.273.29 
III 
I 20.352.52 43.182.71 1.641.43 1.271.01 37.364.20 16.554.57 
F 20.212.78 38.366.50 1.361.03 1.271.01 42.646.65 16.364.46 
R
1
 19.80-32.60 19.80-32.60 1.50-2.70 1.70-4.30 45.00-75.00 8.10-16.50 
R
2
 20.00-30.00 13.00-49.00 2.00-14.00 1.00-17.00 31.00-72.00 1.00-4.00 
R
3
 13.00-32.00 20.00-31.00 1.00-3.50 1.50-4.00 50.00-70.00 6.00-11.00 
R
4
 25.00 25.00 4.00 2.00 62.00 4.00 
R
5
 - 13.00-35.00 1.20-2.50 2.10-3.10 58.00-76.00 1.10-6.50 
Note: Pre= ante- treatment; Post = post- treatment; I=initial; F=final.  
R1-Gylstorff I., 1983, Handbuch der Geflügelphysiologie. Diseases of Exoic Animals 
Wallach JD, Boever WJ;  
R
2
-Hoffmann G., 1961, Abriss der Laboratoriumstierkunde. Veb Gustav Fisher Verlag 
Jena; 
R
3
-Pîrvu Gh., I. Barna, A. Caprarin, 1984, Hematologie veterinară practică. Ed.Ceres, 
Bucuresti;  
R
4
-Ghergariu S., Al. Pop, L. Kadar, Marina Spânu, 2000, Manual de laborator clinic 
veterinar. Ed. All Bucureşti; 
R
5
-Uray Z., 1992, Ghid de date bilologice şi fiziologice ale animalelor de laborator. 
Biologia animalelor de laborator şi oncologie comparată, Vol 19. 
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The abundance of reference data and the controversies between them increased 
considerably the difficulty of interpreting and framing the physiological ranges of individual 
and mean values for the leucogram parameters (table 2).  
Thus, the total number of leukocytes varied in the interval between 15.162.52 – 
20.352.52 G/L situated within the physiological limits (13.00 to 32.00 G/L) only by one 
source (Pîrvu et al, 1984), the rest placing the observed means of the experimental groups 
under physiological limit (Uray, 1992; Ghergariu et al., 2000; Hoffmann, 1961; Gylstorff, 
1983). Moreover, post-treatment decreases the total number of leukocytes in the experimental 
groups (16.753.40 G/L, respectively 15.473.02 G/L) compared to the control group 
(20.212.78G/L) were statistically significant (p <0.05). 
Likewise developments in the leukocyte subpopulations highlighted large variations 
falling within some of the mentioned reference intervals and some situated beyond, of grater 
or lesser important than others. Thus, the proportions of PMN leukocytes showed oscillations 
between 38.366.50 and 43.182.71% in case of heterophiles, 1.360.92 and 1.911.30 % for 
eosinophils, respectively 0.820.87 and 1.271.01% for basophils. Lesser variations 
presented the proportion of lymphocytes (37.36  4.20 to 43.45  11.5%) and monocytes 
(12.55  3.27 -16.55 4.57%). 
Particular relevance was given to the statistical analysis to the leucogram values, 
which showed significant differences (p<0.05) only for the control group, consisting of a 
lower percentage of heterophiles (from 43.182.71 to 38.366.50) and increase in 
lymphocytes (from 37.364.20 to 42.646.65%), due to individual cases of mild heteropenia 
and/or lymphocytosis. 
 Also it is important to emphasize that no significant decreases in post-treatment total 
number of leukocytes or leukocyte subpopulations was observed to suggest the presence of 
hypersensitivity or immunosuppression drug phenomena. 
Tab. 3. 
The values of the probability index”p” in the investigated groups of broilers 
Parameter 
I II III I/II I/III II/III 
Pre 
Pos
t 
Pr
e 
Pos
t 
I F 
Pos
t 
Pos
t 
Pos
t 
F 
Pos
t 
F 
PCV 0.7963 0.6437 0.6453 0.3082 0.5457 0.6543 
Hb 0.5459 0.6977 0.9297 > 0.9999 0.2734 0.2667 
Erythrocytes 0.5902 0.2196 0.9515 0.3447 0.0429 0.2101 
Mean 
erythrocyt
e 
constants 
MCV 0.5556 0.2935 0.6813 0.2935 0.0802 0.6596 
MCH 0.5188 0.6611 0.8906 0.5384 0.0466 0.1178 
MCHC 0.8514 0.4569 0.773 0.5292 0.6119 0.2477 
Leukocytes 0.9693 0.7965 0.9027 0.3617 0.0167* 0.0010* 
Leucogra
m 
heterophile 0.7969 0.5333 
0.0344
* 
0.4823 0.2557 0.8881 
eosinophil
e 
0.4613 0.7534 0.6040 > 0.9999 0.4782 0.4782 
lymphocyt
e 
0.9163 0.5309 
0.0376
* 
0.8840 0.9551 0.8427 
monocytes 0.4346 0.9082 0.9224 0.0660 0.0334* 0.5216 
Note: Pre= ante- treatment; Post = post- treatment; I=initial; F=final;  
*= statistically significant. 
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Comparative analysis of the values obtained for the investigated parameters with 
bibliographic sources indicated some uncertainty in interpreting the results, with potential 
controversy arising from physiological ranges reported by various authors.  
However, in the absence of statistically significant changes between the mean pre-and 
post-therapeutic values in the main hematological indices of the experimental groups, we 
considered that no alterations occurred after treatment with erythromycin thiocyanate. 
 
CONCLUSIONS 
 
 Analysis of the development of physiological parameters in the investigated groups of 
broilers revealed mean value variations from one group to another, falling within 
physiological intervals for the species and category, or slight deviations from some 
references, and the ranges established in the control group;  
 Comparative developments pre-and post-treatment of hematological parameters have 
outlined a normal profile for the category of investigated broilers, indicating a good 
tolerance of therapeutic and double doses of erythromycin thiocyanate and no negative 
effects on electrolyte balance and erythrocyte homeostasis, erythropoiesis and general 
erythrocyte functions;  
 Mean variations of the PCV (37.005.44-39.683.48%), hemoglobin concentration 
(6.881.07-7.771.03g/dL) and total number of erythrocytes (2.280.19-2.680.36 T/L) 
were within the physiological intervals reported in some reference sources, or situated at 
the lower limits of others, showing a decreasing trend; 
 MCV mean values (141.1829.49-174.2113.24 fL) exceeded some physiological 
intervals in the experimental groups, while MCH (26.535.79-34.365.78 pg) and MCHC 
(18.553.73-20.684.65g/dL) were below the values found in most references also 
showing a decreasing trend; 
 An overview of obtained data in the determined leukocyte parameters outlined specific 
aspects with a good defensive potential, both for the group treated with therapeutic and 
double dose of erythromycin thiocyanate; 
 Evolution of the mean values of total number of leucocytes (15.162.52-20.352.52G/L) 
and leukocyte subpopulations distribution, indicated a high level of tolerance to 
therapeutic and double doses of erythromycin thiocyanate confirming and lack of 
sensitization or adverse effects on leukocyte functions in general and leucopoiesis; 
 Statistical analysis highlighted significant differences (p<0.05) only for the control group, 
consisting of a lower the percentage of heterophiles (from 43.182.71 to 38.366.50) and 
increase in lymphocytes (from 37.364.20 to 42.646.65%), due to individual cases of 
mild heteropenia and/or lymphocytosis;  
 Clinical and hematological monitoring of some physiological health indicators has 
identified no potential risks associated with doubling the dose as an experimental variable; 
doses of 10 and 20 mg erythromycin/individual/day, administered for 7 consecutive days, 
were not followed by immediate or delayed side effects, or any sign of 
immunosuppression. 
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